Philippe Moreillon
Overview
Explore the profile of Philippe Moreillon including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
89
Citations
3480
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
van der Vaart T, Bossuyt P, Durack D, Baddour L, Bayer A, Durante-Mangoni E, et al.
Clin Infect Dis
. 2024 Feb;
78(4):922-929.
PMID: 38330166
Background: The 2023 Duke-International Society of Cardiovascular Infectious Diseases (ISCVID) criteria for infective endocarditis (IE) were introduced to improve classification of IE for research and clinical purposes. External validation studies...
2.
Theys H, Van den Eynde J, Herregods M, Moreillon P, Heying R, Oosterlinck W
JTCVS Open
. 2022 Aug;
8:301-312.
PMID: 36004157
Objective: Antiaggregants (Ag) could prevent infective endocarditis (IE) in preclinical studies. In this study we investigated whether Ag or anticoagulants (Ac) were also protective in humans. Methods: In part I...
3.
McCallin S, Menzi C, Lassen S, Daraspe J, Oechslin F, Moreillon P
Antimicrob Agents Chemother
. 2022 Jun;
66(7):e0224721.
PMID: 35708333
In the time of antimicrobial resistance, phage therapy is frequently suggested as a possible solution for such difficult-to-treat infections. Vancomycin-intermediate Staphylococcus aureus (VISA) remains a relatively rare yet increasing occurrence...
4.
Oechslin F, Menzi C, Moreillon P, Resch G
J Biol Chem
. 2021 Apr;
296:100639.
PMID: 33838182
Endolysins are peptidoglycan hydrolases produced at the end of the bacteriophage (phage) replication cycle to lyse the host cell. Endolysins in Gram-positive phages come in a variety of multimodular forms...
5.
Conen A, Stortecky S, Moreillon P, Hannan M, Franzeck F, Jeger R, et al.
EuroIntervention
. 2020 Mar;
16(14):1135-1140.
PMID: 32207407
Infective endocarditis (IE) after transcatheter aortic valve implantation (TAVI) is a new disease entity. The rate of IE after TAVI is similar to that after surgical aortic valve replacement (SAVR),...
6.
Ditkowski B, Bezulska-Ditkowska M, Jashari R, Baatsen P, Moreillon P, Rega F, et al.
J Thorac Cardiovasc Surg
. 2020 Jan;
161(6):e457-e472.
PMID: 31926702
Objective: Although recent advances in pulmonary valve replacement have enabled excellent hemodynamics, infective endocarditis remains a serious complication, particularly for implanted bovine jugular vein (BJV) conduits. Methods: We investigated contributions...
7.
Heying R, Vanassche T, Moreillon P
JAMA Cardiol
. 2019 Sep;
4(11):1177.
PMID: 31483440
No abstract available.
8.
Mancini S, Oechslin F, Menzi C, Que Y, Claes J, Heying R, et al.
Virulence
. 2018 Oct;
9(1):1615-1624.
PMID: 30280967
Staphylococcus aureus is the leading cause of infective endocarditis (IE). While the role of S. aureus cell-wall associated protein clumping factor A (ClfA) in promoting IE has been already demonstrated,...
9.
Claes J, Ditkowski B, Liesenborghs L, Veloso T, Entenza J, Moreillon P, et al.
Thromb Haemost
. 2018 Jun;
118(7):1230-1241.
PMID: 29909601
Adhesion of to endothelial cells (ECs) is paramount in infective endocarditis. Bacterial proteins such as clumping factor A (ClfA) and fibronectin binding protein A (FnbpA) mediate adhesion to EC surface...
10.
Larpin Y, Oechslin F, Moreillon P, Resch G, Entenza J, Mancini S
PLoS One
. 2018 Feb;
13(2):e0192507.
PMID: 29408864
The recent rise of multidrug-resistant Gram-negative bacteria represents a serious threat to public health and makes the search for novel effective alternatives to antibiotics a compelling need. Bacteriophage (Phage) lysins...